0001562180-19-002182.txt : 20190403
0001562180-19-002182.hdr.sgml : 20190403
20190403163054
ACCESSION NUMBER: 0001562180-19-002182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saccomano Nicholas A
CENTRAL INDEX KEY: 0001609284
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 19729398
BUSINESS ADDRESS:
BUSINESS PHONE: 303-381-6600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-04-01
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001609284
Saccomano Nicholas A
C/O ARRAY BIOPHARMA INC.
3200 WALNUT STREET
BOULDER
CO
80301
false
true
false
false
CSO
Common Stock
2019-04-01
4
M
false
13750.00
0.00
A
156238.00
D
Common Stock
2019-04-01
4
F
false
6048.00
24.60
D
150190.00
D
Restricted Stock Units
0.00
2019-04-01
4
M
false
6875.00
0.00
D
Common Stock
6875.00
0.00
D
Restricted Stock Units
0.00
2019-04-01
4
M
false
6875.00
0.00
D
Common Stock
6875.00
6875.00
D
Shares issued upon settlement of Restricted Stock Units ("RSUs") granted on April 1, 2015 and April 1, 2016, as a result of the vesting of one fourth of such RSUs.
Represents shares withheld to satisfy tax withholding obligations of the reporting person.
The RSUs vested and settled in stock in four equal annual installments beginning April 1, 2015.
The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2016.
Jason Haddock, attorney-in-fact for Nicholas A. Saccomano
2019-04-03